Medical Supplies for Pandemics Act of 2020
Latest action · Apr 17, 2020 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 17, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medical Supplies for Pandemics Act of 2020
This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies. Specifically, HHS must (1) create incentives for manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture.
The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2023.
Cosponsors 10
Members who signed on, in the order they did. Signatures ran from Apr 17, 2020 to Jun 11, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IN | Jackie Walorski | Original | Apr 17, 2020 |
| R-MI | Fred Upton | Apr 22, 2020 | |
| D-NY | Eliot L. Engel | Apr 23, 2020 | |
| R-WV | David B. McKinley | May 1, 2020 | |
| R-TX | Pete Olson | May 1, 2020 | |
| R-IN | Susan W. Brooks | May 1, 2020 | |
| D-DC | Eleanor Holmes Norton | May 12, 2020 | |
| D-MI | Elissa Slotkin | May 12, 2020 | |
| D-TX | Sheila Jackson Lee | May 12, 2020 | |
| D-NJ | Jefferson Van Drew | Jun 11, 2020 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 17, 2020 |
Actions 2
Everything that happened, newest first.
- Apr 17, 2020Introduced in House
- Apr 17, 2020Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 73, April 17, 2020, page H1894.
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46507 | FDA’s Role in the Medical Product Supply Chain and Considerations During COVID-19 Archived | Report | Sep 1, 2020 |
| R46319 | Novel Coronavirus 2019 (COVID-19): Q&A on Global Implications and Responses Archived | Report | May 14, 2020 |
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 3827 | Medical Supplies for Pandemics Act of 2020 | Identical bill | May 21, 2020 |
| HR 6800 | The Heroes Act | Related bill | Jul 23, 2020 |
| HR 7574 | Strengthening America’s Strategic National Stockpile Act of 2020 | Related bill | Sep 22, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Public Health Service Act to authorize the use of the Strategic National Stockpile to enhance medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies, and for other purposes.
- Short Title(s) as Introduced
- Medical Supplies for Pandemics Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Congressional oversight
- Emergency medical services and trauma care
- Health
- Health programs administration and funding
- Health technology, devices, supplies
- Immunology and vaccination
- Manufacturing
- Medical tests and diagnostic methods
- Prescription drugs
- Public contracts and procurement
- Strategic materials and reserves
Text 1
Each version as it was printed, newest first.
- Apr 17, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
